Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03930446Phase 1Completed
Phase 1, randomised, double-blind trial (2 arms), sponsored by University of Chicago. Primary endpoint: Stop Signal Task. Started Jan 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03930446.